EX-23.2 4 ctmx-ex232_6.htm EX-23.2 ctmx-ex232_6.htm

 

Exhibit 23.2

CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-214418, 333-216567, 333-228203) and Form S-8 (Nos. 333-207694, 333-209992, 333-215795, 333-223491) of CytomX Therapeutics, Inc. of our report dated March 2, 2017 relating to the financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, California

February 27, 2019